T2 Biosystems Presents Data on Novel Method for Endotoxin Detection at ASM 2012
6/18/2012 10:11:36 AM
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of data on endotoxin detection at the American Society for Microbiology General Meeting, June 16-19, 2012, in San Francisco, CA. The T2Endotoxin assay is a novel method to screen injectable drugs and medical devices for the presence of endotoxins that are produced by gram negative bacteria or fungi, combining the standard Limulus Amoebocyte Lysate (LAL) reagent with Company’s T2MR technology. LAL forms a gel in response to the presence of endotoxin and changes in LAL are directly measured by T2MR, similar to the T2Hemostasis application for coagulation and platelet disorders. The data presented at ASM demonstrate that the T2Endotoxin assay provided higher sensitivity, faster detection and lower reagent consumption when compared with commercially available assays.